This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1972 Apr;61(4):541-4.

doi: 10.1002/jps.2600610409.

Relationship between dose and plateau levels of drugs eliminated by parallel first-order and capacity-limited kinetics

T Tsuchiya, G Levy

PMID: 5014310
DOI: 10.1002/jps.2600610409

Relationship between dose and plateau levels of drugs eliminated by parallel first-order and capacity-limited kinetics

T Tsuchiya et al. J Pharm Sci. 1972 Apr.

. 1972 Apr;61(4):541-4.

doi: 10.1002/jps.2600610409.

Authors

T Tsuchiya, G Levy

PMID: 5014310
DOI: 10.1002/jps.2600610409

No abstract available

PubMed Disclaimer

Similar articles

Dose-dependent decline of pharmacologic effects of drugs with linear pharmacokinetic characteristics.
Gibaldi M, Levy G. Gibaldi M, et al. J Pharm Sci. 1972 Apr;61(4):567-9. doi: 10.1002/jps.2600610414. J Pharm Sci. 1972. PMID: 5014313 No abstract available.
Interactive simulator for pharmacokinetics of repetitive drug dosing.
Iben GA, Anderson JH. Iben GA, et al. Comput Programs Biomed. 1975 Mar;4(3):113-20. doi: 10.1016/0010-468x(75)90013-6. Comput Programs Biomed. 1975. PMID: 1139911
Route of administration and drug metabolism.
Gibaldi M, Feldman S. Gibaldi M, et al. Eur J Pharmacol. 1972 Sep;19(3):323-9. doi: 10.1016/0014-2999(72)90098-2. Eur J Pharmacol. 1972. PMID: 4640856 No abstract available.
Pharmacokinetic aspects of drug metabolism.
Gibaldi M. Gibaldi M. Ann N Y Acad Sci. 1971 Jul 6;179:19-31. doi: 10.1111/j.1749-6632.1971.tb46888.x. Ann N Y Acad Sci. 1971. PMID: 4936775 Review. No abstract available.
[Biochemical aspects of clinical pharmacology. Problems of kinetics].
Wysokowski J, Rewerski W. Wysokowski J, et al. Pol Tyg Lek. 1971 Feb 22;26(8):288-90. Pol Tyg Lek. 1971. PMID: 4927667 Review. Polish. No abstract available.

See all similar articles

Cited by

A modern view of pharmacokinetics.
Wagner JG. Wagner JG. J Pharmacokinet Biopharm. 1973 Oct;1(5):363-401. doi: 10.1007/BF01059664. J Pharmacokinet Biopharm. 1973. PMID: 4599379 Review. No abstract available.
Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol.
Alván G, Lind M, Mellström B, von Bahr C. Alván G, et al. J Pharmacokinet Biopharm. 1977 Jun;5(3):193-205. doi: 10.1007/BF01065395. J Pharmacokinet Biopharm. 1977. PMID: 881641 No abstract available.
The unsteady model. An alternative approach to nonlinear pharmacokinetics.
Smith MT, Smith TC. Smith MT, et al. Eur J Clin Pharmacol. 1981;20(5):387-98. doi: 10.1007/BF00615410. Eur J Clin Pharmacol. 1981. PMID: 7286050
Monitoring plasma concentrations of salicylate.
Mandelli M, Tognoni G. Mandelli M, et al. Clin Pharmacokinet. 1980 Sep-Oct;5(5):424-40. doi: 10.2165/00003088-198005050-00002. Clin Pharmacokinet. 1980. PMID: 7408367
Area-dose relationships in nonlinear models.
Chau NP. Chau NP. J Pharmacokinet Biopharm. 1976 Dec;4(6):537-51. doi: 10.1007/BF01064557. J Pharmacokinet Biopharm. 1976. PMID: 1011077 No abstract available.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Wiley